Article
Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.
Blood cells, molecules & diseases - 15 Mar 2011
Neishabury Maryam, Azarkeivan Azita, Oberkanins Christian, Abedini Seyedeh Sedigheh, Zamani Shahbaz, Najmabadi Hossein
Abstract excerpt
Our data on 114 Iranian individuals with thalassemia intermedia phenotype revealed homozygous or compound heterozygous beta-globin mutations to be the predominant disease factor in 86.2% of cases. However, 8.2% of these individuals were found to be heterozygous or wild type for beta-globin mutations. In search for determinants outside of the beta-globin gene, which could be responsible for the unexpected...
Topics
- Adolescent
- Adult
- Child
- Female
- Genotype
- Heterozygote
- Humans
- Iran
- Locus Control Region
- Male
- Middle Aged
